Want to see HK:1717 full AI Analyst Report?
1717 Stock Chart & Stats
HK$2.01
-HK$0.01(-0.54%)
At close: 4:00 PM EST
HK$2.01
-HK$0.01(-0.54%)
Day’s Range― - ―
52-Week RangeHK$1.01 - HK$2.52
Previous CloseN/A
Volume47.00K
Average Volume (3M)57.10K
Market Cap
HK$1.81B
Enterprise ValueHK$4.18B
Total Cash (Recent Filing)HK$931.67M
Total Debt (Recent Filing)HK$2.62B
Price to Earnings (P/E)―
Beta0.49
Next Earnings
Mar 31, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield4.9%
Share Statistics
EPS (TTM)0.10
Shares Outstanding1,778,144,900
10 Day Avg. Volume68,500
30 Day Avg. Volume57,100
Financial Highlights & Ratios
PEG Ratio-0.77
Price to Book (P/B)0.53
Price to Sales (P/S)0.42
P/FCF Ratio20.68
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$2.10Price Target Upside4.48% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.28
Revenue Forecast (FY)HK$7.51B
Bulls Say, Bears Say
Bulls Say
2025 Revenue ReboundThe strong 2025 revenue rebound indicates that Ausnutria regained sales momentum after weakness in 2022–2024. If supported by continued demand for its branded infant formula and nutrition products, improved scale can strengthen channel relevance and provide a foundation for recovering earnings.
Manageable LeverageModerate leverage and a growing equity base provide Ausnutria with meaningful financial stability. Debt-to-equity remains manageable for a packaged foods company, preserving capacity to fund operations and product development while reducing the balance-sheet strain that would accompany more aggressive borrowing.
Positive 2025 Free Cash FlowThe return to positive free cash flow in 2025 is an important improvement in internal funding capacity. Although consistency still needs to be demonstrated, positive cash generation can support reinvestment, debt servicing and shareholder returns without relying as heavily on external financing.
Bears Say
Structural Margin CompressionThe sustained decline in gross and net margins shows that revenue recovery has not restored earlier earnings quality. Lower profitability may reflect weaker pricing power or higher cost intensity, leaving less operating leverage and making future earnings more sensitive to sales execution and expenses.
Volatile Cash ConversionSeveral years of negative free cash flow indicate that reported revenue and earnings have not consistently converted into discretionary cash. This volatility can constrain reinvestment and shareholder distributions, while the 2025 improvement remains less dependable until sustained across additional reporting periods.
Low Return On EquityThe sharp reduction in return on equity indicates that Ausnutria is generating substantially less profit from its capital base than it did previously. Even with acceptable solvency, weak returns can limit retained-earnings growth and signal that the business is using its resources less efficiently.
Ausnutria Dairy Corp. Ltd. News
1717 FAQ
What was Ausnutria Dairy Corp. Ltd.’s price range in the past 12 months?
Ausnutria Dairy Corp. Ltd. lowest stock price was HK$1.01 and its highest was HK$2.52 in the past 12 months.
What is Ausnutria Dairy Corp. Ltd.’s market cap?
Ausnutria Dairy Corp. Ltd.’s market cap is HK$1.81B.
When is Ausnutria Dairy Corp. Ltd.’s upcoming earnings report date?
Ausnutria Dairy Corp. Ltd.’s upcoming earnings report date is Mar 31, 2027 which is in 170 days.
How were Ausnutria Dairy Corp. Ltd.’s earnings last quarter?
Ausnutria Dairy Corp. Ltd. released its earnings results on Aug 26, 2026. The company reported -HK$0.464 earnings per share for the quarter.
Is Ausnutria Dairy Corp. Ltd. overvalued?
According to Wall Street analysts Ausnutria Dairy Corp. Ltd.’s price is currently Undervalued.
Does Ausnutria Dairy Corp. Ltd. pay dividends?
Ausnutria Dairy Corp. Ltd. pays a Annually dividend of HK$0.05 which represents an annual dividend yield of 4.9%. See more information on Ausnutria Dairy Corp. Ltd. dividends here
What is Ausnutria Dairy Corp. Ltd.’s EPS estimate?
Ausnutria Dairy Corp. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ausnutria Dairy Corp. Ltd. have?
Ausnutria Dairy Corp. Ltd. has 1,778,144,900 shares outstanding.
What happened to Ausnutria Dairy Corp. Ltd.’s price movement after its last earnings report?
Ausnutria Dairy Corp. Ltd. reported an EPS of -HK$0.464 in its last earnings report. Following the earnings report the stock price went down -2.075%.
Which hedge fund is a major shareholder of Ausnutria Dairy Corp. Ltd.?
Currently, no hedge funds are holding shares in HK:1717
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Ausnutria Dairy Corp. Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-57.71%
12-Months-Change
Fundamentals
Return on Equity
-11.03%
Trailing 12-Months
Asset Growth
-2.27%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Ausnutria Dairy Corp. Ltd.
Ausnutria Dairy Corporation Ltd, an investment holding firm, is primarily involved in the entire lifecycle of infant formula and other dairy products, encompassing research and development, milk sourcing, processing, manufacturing, packaging, marketing, and distribution. Its operations are divided into two main divisions: Dairy and Related Products, and Nutrition Products. The company markets cow milk-based formula products under brand names such as Allnutria, Hyproca Hollary, Hyproca Hypure, Neolac, and Puredo. Additionally, its goat milk-based infant formula is sold under the Kabrita brand. Ausnutria also functions as an original equipment manufacturer (OEM) for formula milk powder products. Beyond dairy, it manufactures and distributes various nutrition products, develops and sells probiotic items, and offers financing solutions. Its global footprint spans the People's Republic of China, the European Union, Southeast Asia, Australia, New Zealand, the Middle East, North and South America, and other international markets. Established in 2003, Ausnutria Dairy Corporation Ltd is headquartered in Sheung Wan, Hong Kong, and operates as a subsidiary of HongKong Jingang Trade Holding Company Limited.
1717 Stock 12 Month Forecast
Average Price Target
HK$2.10
▲(4.48% Upside)
Technical Analysis
Want Want China Holdings
―
Health and Happiness (H&H) International Holdings
―
China Mengniu Dairy Co
―
Vitasoy International Holdings
―
China Feihe Limited
―